USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS
    2.
    发明公开
    USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS 有权
    1,3-二苯基丙-2-烯-1-酮衍生物用于治疗肝脏疾病的应用

    公开(公告)号:EP2504005A1

    公开(公告)日:2012-10-03

    申请号:EP10787363.0

    申请日:2010-11-26

    申请人: Genfit

    摘要: The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease.

    摘要翻译: 本发明提供了1,3-二苯基丙-2-烯-1-酮衍生物和包含其的用于治疗肝脏疾病的药物组合物,特别是那些需要降低生化标志物如氨基转移酶的血浆水平的药物组合物。 通式(I)的1,3-二苯基丙-2-烯-1-酮衍生物具有肝保护性质,并且可用于治疗涉及肝细胞的病理性破坏,炎症,变性和/或增殖的肝病的方法 如肝纤维化或脂肪肝病。